Age-related Changes in Rat Myocardium Involve Altered Capacities of Glycosaminoglycans to Potentiate Growth Factor Functions and Heparan Sulfate-altered Sulfation
Open Access
- 1 March 2012
- journal article
- Published by Elsevier BV
- Vol. 287 (14), 11363-11373
- https://doi.org/10.1074/jbc.m111.335901
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Gene therapy for ischemic heart diseaseJournal of Molecular and Cellular Cardiology, 2011
- The Heparan Sulfate Motif (GlcNS6S-IdoA2S)3, Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and DiseaseJournal of Biological Chemistry, 2010
- Characterization of the Human Sulfatase Sulf1 and Its High Affinity Heparin/Heparan Sulfate Interaction DomainPublished by Elsevier BV ,2009
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- Protein quality control and degradation in cardiomyocytesJournal of Molecular and Cellular Cardiology, 2008
- Characterization of anticoagulant heparinoids by immunoprofilingGlycoconjugate Journal, 2007
- Cardiovascular gene therapy: current status and therapeutic potentialBritish Journal of Pharmacology, 2007
- Fibroblast growth factor-2 and cardioprotectionHeart Failure Reviews, 2007
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 2006
- Identification of Common and Specific Growth Factor Binding Sites in Heparan Sulfate ProteoglycansBiochemistry, 2005